Oestradiol and immunoreactive inhibin-like secretory patterns following controlled ovarian hyperstimulation with urinary (Metrodin) or recombinant follicle stimulating hormone (Puregon)

Human Reproduction

Volumn 11, Issue 5, 1996, Pages 962-967

  Mitchell, R ^a   Buckler, H M ^a   Matson, P ^b   Lieberman, B ^b   Burger, H G ^c   Hilton, B ^a   Horne, G ^b   Dyson, M ^c   Robertson, W R ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

FSH; Inhibin; IVF; Recombinant proteins

Indexed keywords

BUSERELIN; CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; INHIBIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; UROFOLLITROPIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG POTENCY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FOLLITROPIN BLOOD LEVEL; HORMONE RELEASE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OOCYTE; OVARY FOLLICLE DEVELOPMENT; OVARY HYPERSTIMULATION; PATIENT MONITORING; RANDOMIZED CONTROLLED TRIAL;

EID: 0029995406     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.humrep.a019332     Document Type: Article

References (35)

1. Buckler, H.M., Robertson, W.R., Sun, J.G. and Morris. I.D. (1992) Immunoreactive inhibin levels during ovarian stimulation may predict granulosa cell maturity. Clin. Endocrinol., 37, 552-557.
2. Burger, H.G. (1993) CLINICAL REVIEW 46: clinical utility of inhibin measurements. J. Clin. Endocrinol. Metab., 76, 1391-1396.
3. Burger, H.G. (1994) Inhibin as a tumour marker. Clin. Endocrinol., 41, 151-153.
4. Devroey, P., Mannaerts, B., Smitz, J., Coelingh Bennink, H. and Van Steirteghem, A. (1994) Clinical outcome of a pilot efficacy study on recombinant human follicle-stimulating hormone (ORG 32489) combined with various gonadotrophin-releasing hormone agonist regimes. Hum. Reprod., 9, 1064-1069.
5. Giudice, E., Crisci, C, Eshkol, A. and Papoian, R. (1994) Composition of commercial gonadotrophin preparations extracted from human post-menopausal urine: characterization of non-gonadotrophin proteins. Hum. Reprod., 9, 2291-2299.
6. Groome, N.P., Illingworth, P.J., O'Brien, M. et al. (1994) Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay. Clin. Endocrinol., 40, 717-723.
7. Harris, S.D., Mitchell, R. and Robertson, W.R. (1995) Glycoforms of recombinant human FSH (ORG 32489); comparison with urinary FSH. J. Reprod. Fertil. Abstr. Ser., 15, Abstr. 107.
8. Hillier, S.G. (1994) Current concepts of the roles of follicle-stimulating hormone and luteinizing hormone in folliculogenesis. Hum. Reprod., 9, 188-191.
9. Hughes, E.G., Robertson, D.M., Handelsman, D.J. et al (1990) Inhibin and estradiol responses to ovarian hyperstimulation: effects of age and predictive value for in vitro fertilization outcome. J. Clin. Endocrinol. Metab., 70, 358-364.
10. Karnitis, V.J., Townson, D.H., Friedman, C.I. and Danforth, D.R. (1994) Recombinant human follicle-stimulating hormone stimulates multiple follicular growth, but minimal estrogen production in gonadotropin-releasing hormone antagonist-treated monkeys: examining the role of luteinizing hormone in follicular development and steroidogenesis. J. Clin. Endocrinol. Metab., 79, 91-97.
11. Lambert, A., Rodgers, M., Mitchell, R. et al (1995) In-vitro biopotency and glycoform distribution of recombinant human FSH (Organon 32489), Metrodin and Metrodin-HP. Hum. Reprod., 10, 1928-1935.
12. Le Cotonnec, J.-Y., Porchet, H.C., Beltrami, V. and Howles, C. (1993) Comparative pharmacokinetics of two urinary human follicle stimulating hormone preparations in healthy female and male volunteers. Hum. Reprod., 8, 1604-1611.
13. Matson, P.L., Morris, I.D., Sun, J.G., Ibrahim, Z.H.Z. and Lieberman, B.A. (1991) Serum inhibin as an index of ovarian function in women undergoing pituitary suppression and ovarian stimulation in an in vitro fertilization program. Hormone Res., 35, 173-177.
14. McLachlan, R.I., Robertson, D.M., Healy, D.L., DeKretser, D.M. and Burger, H.G. (1986a) Plasma inhibin levels during gonadotrophin induced ovarian hyperstimulation for IVF: a new index of follicular function. Lancet, i, 1233-1234.
15. McLachlan, R.I., Robertson, D.M., DeKretser, D.M. and Burger H.G. (1986b) The radioimmunoassay of bovine and human follicular fluid and serum inhibin. Mol. Cell. Endocrinol., 46, 175-185.
16. Minaretzis, D., Alper, M.M., Oskowitz, S.P. et al. (1995) Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells. Am. J. Obstet. Gynecol, 172, 1518-1525.
17. Morse, J.H., Lustbader, J.W., Harrington, J.W. and Canfield, R.E. (1988) Heterogeneity of proteins in commercial preparations of HCG demonstrated by Western blotting. Am. J. Reprod. Immunol. Microbiol, 17, 134-140.
18. Muttukrishna, S., Fowler. P.A., Groome, N.P. et al. (1994) Serum concentrations of dimeric inhibin during the spontaneous human menstrual cycle and after treatment with exogenous gonadotrophin. Hum. Reprod., 9, 1634-1642.
19. Olivennes, F., Fanchin, R., Bouchard, P. et al. (1994) The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer program. Fertil. Steril., 62, 468-476.
20. Out, H.J., Mannaerts, B.M.J.L., Coelingh Bennink, H.J.T. and Driessen, S.G.A.J. for The European Puregon Collaborative IVF Study Group (1995) A prospective, randomized, assessor-blind, multi-centre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization. Hum. Reprod., 10, 2534-2540.
21. Padmanabhan, V., Lang, L.L., Sonstein, J., Kelch, R.P. and Beitins, I.Z. (1988) Modulation of serum follicle-stimulating hormone bioactivity and isoform distribution by estrogenic steroids in normal women and in gonadal dysgenesis. J. Clin. Endocrinol. Metab., 67, 465-473.
22. Papandreou, M.-J., Asteria, C, Pettersson, K., Ronin, C. and Beck-Peccoz, P. (1993) Concanavalin A affinity chromatography of human serum gonadotropins: evidence for changes of carbohydrate structure in different clinical conditions. J. Clin. Endocrinol. Metab., 76, 1008-1013.
23. Paulson, R.J., Sauer, M.V. and Lobo, R.A. (1994) Addition of gonadotropin-releasing hormone (GnRH) antagonist and exogenous gonadotropins to unstimulated in vitro fertilisation (IVF) cycles: physiologic observations and preliminary experience. J. Assist. Reprod. Genet., 11, 28-32.
24. Poncelet, E. and Franchimont. P. (1994) Two-site enzyme-immunoassay of inhibin. Frontiers Endocrinol. Inhibin Inhibin-rel. Proteins, 3, 45-54
25. Recombinant Human FSH Study Group (1995) Clinical assessment of recombinant follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization. Fertil. Steril., 63, 77-86.
26. Rodgers, M., Mitchell, R., Lambert, A., Peers, N. and Robertson, W.R, (1992) Human chorionic gonadotrophin contributes to the bioactivity of Pergonal. Clin. Endocrinol., 37, 558-564.
27. Rodgers, M., McLoughlin, J.D., Lambert, A., Robertson, W.R. and Mitchell, R. (1995) Variability in the immunoreactive and bioactive FSH content of human urinary menopausal gonadotrophin preparations. Hum. Reprod., 10, 1982-1986.
28. Schneyer, A.L., Mason, A.J., Burton, L.E., Zegner, J.R. and Crowley, W.F. (1990) Immunoreactive inhibin α-subunit in human serum: implications for radioimmunoassay. J. Clin. Endocrinol. Metab., 70, 1208-1212.
29. School, D.C., Harlin, J., Shoham, Z. et al. (1994) Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women. Hum. Reprod., 9, 1237-1242.
30. Sommer, L., Zanger, K., Dyong, T. et al. (1994) Seven-day administration of the gonadotropin-releasing hormone antagonist Cetrorelix in normal cycling women. Eur. J. Endocrinol., 131, 280-285.
31. Stokman, P.G., de Leeuw, R., van den Wijngaan, K.A. et al. (1993) Human chorionic gonadotrophin in commercial menopausal gonadotrophin preparations. Fertil. Steril., 60, 175-178.
32. Storring, P.L. (1992) Assaying glycoprotein hormones -the influence of glycosylation on immunoreactivity. Trends Biotechnol., 10, 427-431.
33. Thompson, K.A., LaPolt. P.S., River, J. et al. (1995) Gonadotropin requirements of the developing follicle. Fertil. Steril., 63, 273-276.
34. Wikland, M., Borg, J., Hamberger, L. and Svalander, P. (1994) Simplification of IVF: minimal monitoring and the use of subcutaneous highly purified FSH administration for ovulation induction. Hum. Reprod., 9, 1430-1436.
35. Wilson, C.A., Leigh, A.J. and Chapman, A.J. (1990) Gonadotrophin glycosylation and function. J. Endocrinol., 125, 3-14.